IL157446A0 - Increased recovery of active proteins - Google Patents
Increased recovery of active proteinsInfo
- Publication number
- IL157446A0 IL157446A0 IL15744602A IL15744602A IL157446A0 IL 157446 A0 IL157446 A0 IL 157446A0 IL 15744602 A IL15744602 A IL 15744602A IL 15744602 A IL15744602 A IL 15744602A IL 157446 A0 IL157446 A0 IL 157446A0
- Authority
- IL
- Israel
- Prior art keywords
- active proteins
- increased recovery
- proteins
- preparations
- reduction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Measurement Of Radiation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27103301P | 2001-02-23 | 2001-02-23 | |
PCT/US2002/005645 WO2002068455A2 (en) | 2001-02-23 | 2002-02-22 | Efficient recovery of correctly refolded proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157446A0 true IL157446A0 (en) | 2004-03-28 |
Family
ID=23033913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15744602A IL157446A0 (en) | 2001-02-23 | 2002-02-22 | Increased recovery of active proteins |
Country Status (21)
Country | Link |
---|---|
US (2) | US7157557B2 (bg) |
EP (1) | EP1366062B1 (bg) |
JP (1) | JP2005505494A (bg) |
KR (1) | KR20040052481A (bg) |
CN (1) | CN1547586A (bg) |
AT (1) | ATE517909T1 (bg) |
AU (1) | AU2002255600B2 (bg) |
BG (1) | BG108087A (bg) |
CA (1) | CA2438094C (bg) |
CZ (1) | CZ20032208A3 (bg) |
EE (1) | EE200300408A (bg) |
ES (1) | ES2370235T3 (bg) |
HK (1) | HK1059267A1 (bg) |
HU (1) | HUP0303246A2 (bg) |
IL (1) | IL157446A0 (bg) |
MX (1) | MXPA03007563A (bg) |
PL (1) | PL374045A1 (bg) |
RU (1) | RU2316563C2 (bg) |
SK (1) | SK10472003A3 (bg) |
WO (1) | WO2002068455A2 (bg) |
ZA (1) | ZA200305909B (bg) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7157557B2 (en) * | 2001-02-23 | 2007-01-02 | Immunex Corporation | Increased recovery of active proteins |
DK2520654T3 (en) | 2003-08-26 | 2017-05-01 | Univ Colorado Regents | Inhibitors of serine protease activity and their use in methods and compositions for the treatment of bacterial infections |
WO2006060083A1 (en) * | 2004-10-22 | 2006-06-08 | Amgen Inc. | Methods for refolding polypeptides |
KR101370253B1 (ko) * | 2004-10-22 | 2014-03-05 | 암젠 인크 | 재조합 항체의 재접힘 방법 |
JP2008528006A (ja) * | 2005-01-28 | 2008-07-31 | アポロ ライフ サイエンシズ リミテッド | 分子およびそのキメラ分子 |
WO2006125207A2 (en) | 2005-05-19 | 2006-11-23 | Amgen Inc. | Compositions and methods for increasing the stability of antibodies |
SG162788A1 (en) | 2005-06-14 | 2010-07-29 | Amgen Inc | Self-buffering protein formulations |
EP2360170A3 (en) * | 2005-06-17 | 2012-03-28 | Novo Nordisk Health Care AG | Selective reduction and derivatization of engineered proteins comprinsing at least one non-native cysteine |
NZ568809A (en) | 2005-12-22 | 2011-08-26 | Genentech Inc | Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents |
US9012605B2 (en) | 2006-01-23 | 2015-04-21 | Amgen Inc. | Crystalline polypeptides |
RU2439076C2 (ru) | 2006-07-14 | 2012-01-10 | Дженентек, Инк. | Способ выделения повторно свернутого рекомбинантного белка из культуры прокариотических клеток (варианты) |
WO2008051363A2 (en) | 2006-10-20 | 2008-05-02 | Amgen Inc. | Stable polypeptide formulations |
SG10202005450PA (en) | 2007-07-09 | 2020-07-29 | Genentech Inc | Prevention of disulfide bond reduction during recombinant production of polypeptides |
EP2197911A2 (en) * | 2007-09-14 | 2010-06-23 | Amgen Inc. | Homogeneous antibody populations |
WO2011005488A1 (en) | 2009-06-22 | 2011-01-13 | Amgen Inc. | Refolding proteins using a chemically controlled redox state |
CA2765154A1 (en) | 2009-06-25 | 2010-12-29 | Amgen Inc. | Capture purification processes for proteins expressed in a non-mammalian system |
US9005926B2 (en) | 2009-10-02 | 2015-04-14 | Biogen Idec Ma Inc. | Methods of preventing and removing trisulfide bonds |
JP2013512674A (ja) * | 2009-12-02 | 2013-04-18 | アクセルロン ファーマ, インコーポレイテッド | Fc融合タンパク質の血清半減期を増加させるための組成物および方法 |
LT2767546T (lt) | 2011-02-07 | 2019-02-25 | Cerenis Therapeutics Holding Sa | Lipoproteino kompleksai ir jų gamyba bei panaudojimai |
EP2718328A4 (en) | 2011-06-08 | 2014-12-24 | Acceleron Pharma Inc | COMPOSITIONS AND METHODS FOR INCREASING THE HALF TIME OF SERUM |
CA2839917A1 (en) | 2011-06-24 | 2012-12-27 | The Regents Of The University Of Colorado, A Body Corporate | Compositions, methods and uses for alpha-1 antitrypsin fusion molecules |
WO2013106589A1 (en) | 2012-01-10 | 2013-07-18 | The Regents Of The University Of Colorado, A Body Corporate | Compositions, methods and uses for alpha-1 antitrypsin fusion molecules |
US9353165B2 (en) * | 2012-07-25 | 2016-05-31 | Grifols, S.A. | Purification of cell culture derived alpha1 protease inhibitor |
SG11201408530YA (en) | 2012-08-02 | 2015-03-30 | Hoffmann La Roche | Method for producing monomeric and multimeric molecules and uses thereof |
EP2895188B1 (en) | 2012-09-11 | 2017-11-15 | Coherus Biosciences, Inc. | Correctly folded etanercept in high purity and excellent yield |
RU2768003C2 (ru) | 2013-03-08 | 2022-03-22 | Джензим Корпорейшн | Интегрированное непрерывное производство терапевтических белковых лекарственных веществ |
TWI671312B (zh) | 2014-01-17 | 2019-09-11 | 美商健臻公司 | 無菌層析法及製法 |
TWI709569B (zh) | 2014-01-17 | 2020-11-11 | 美商健臻公司 | 無菌層析樹脂及其用於製造方法的用途 |
AR103172A1 (es) | 2014-12-22 | 2017-04-19 | Novartis Ag | Reducción selectiva de residuos de cisteina en anticuerpos il-17 |
JP6884858B2 (ja) | 2016-10-21 | 2021-06-09 | アムジエン・インコーポレーテツド | 医薬製剤及びその製造方法 |
US11369703B2 (en) | 2018-08-31 | 2022-06-28 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
EP3863670A1 (en) | 2018-10-11 | 2021-08-18 | Amgen Inc. | Downstream processing of bispecific antibody constructs |
AU2021410709A1 (en) | 2020-12-22 | 2023-05-25 | Amgen Inc. | Cell culture method |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453363A (en) * | 1985-10-23 | 1995-09-26 | Boehringer Mannheim Gmbh | Process for the activation of t-PA or Ing after genetic expression in prokaryotes |
US4766205A (en) * | 1985-11-13 | 1988-08-23 | Beatrice Companies, Inc. | Method for isolation of recombinant polypeptides in biologically active forms |
AU626524B2 (en) * | 1987-05-29 | 1992-08-06 | Bristol-Myers Squibb Company | Cloning and expression of simian transforming growth factor- beta 1 |
US4970067A (en) * | 1988-12-12 | 1990-11-13 | Helene Curtis, Inc. | Method and composition to condition hair and impart semi-permanent hair set retention properties |
GB8927546D0 (en) | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
AU648214B2 (en) | 1991-12-31 | 1994-04-14 | Lucky Limited | Recombinant gene coding for human alpha interferon and expression vector thereof, etc. |
US5447851B1 (en) * | 1992-04-02 | 1999-07-06 | Univ Texas System Board Of | Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells |
JPH08502661A (ja) * | 1993-08-04 | 1996-03-26 | チバ−ガイギー アクチェンゲゼルシャフト | 高分子量デスルファトヒルジン |
US6310185B1 (en) * | 1994-03-08 | 2001-10-30 | Memorial Sloan Kettering Cancer Center | Recombinant human anti-Lewis Y antibodies |
AU2603995A (en) | 1994-05-25 | 1995-12-18 | University Of Nebraska Board Of Regents | Biologically active glycoprotein hormones produced in procaryotic cells |
EP0772449A1 (en) | 1994-07-22 | 1997-05-14 | F. Hoffmann-La Roche Ag | Pharmaceutical compositions comprising a chimaeric tnf binding protein |
US5879673A (en) * | 1996-01-25 | 1999-03-09 | Genentech, Inc. | Administration of thrombopoietin on a single day only |
US5935824A (en) * | 1996-01-31 | 1999-08-10 | Technologene, Inc. | Protein expression system |
US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
FR2803303B1 (fr) | 2000-01-04 | 2002-05-10 | Aventis Pasteur | Glycoproteine d'enveloppe du vih modifiee chimiquement |
US7157557B2 (en) * | 2001-02-23 | 2007-01-02 | Immunex Corporation | Increased recovery of active proteins |
-
2002
- 2002-02-22 US US10/080,471 patent/US7157557B2/en not_active Expired - Lifetime
- 2002-02-22 KR KR10-2003-7010687A patent/KR20040052481A/ko not_active Application Discontinuation
- 2002-02-22 EP EP02725004A patent/EP1366062B1/en not_active Expired - Lifetime
- 2002-02-22 AT AT02725004T patent/ATE517909T1/de not_active IP Right Cessation
- 2002-02-22 ES ES02725004T patent/ES2370235T3/es not_active Expired - Lifetime
- 2002-02-22 HU HU0303246A patent/HUP0303246A2/hu unknown
- 2002-02-22 MX MXPA03007563A patent/MXPA03007563A/es active IP Right Grant
- 2002-02-22 CA CA2438094A patent/CA2438094C/en not_active Expired - Fee Related
- 2002-02-22 CZ CZ20032208A patent/CZ20032208A3/cs unknown
- 2002-02-22 PL PL02374045A patent/PL374045A1/xx unknown
- 2002-02-22 WO PCT/US2002/005645 patent/WO2002068455A2/en active Application Filing
- 2002-02-22 EE EEP200300408A patent/EE200300408A/xx unknown
- 2002-02-22 RU RU2003127830/13A patent/RU2316563C2/ru active
- 2002-02-22 CN CNA02805444XA patent/CN1547586A/zh active Pending
- 2002-02-22 AU AU2002255600A patent/AU2002255600B2/en not_active Expired
- 2002-02-22 JP JP2002567965A patent/JP2005505494A/ja active Pending
- 2002-02-22 SK SK1047-2003A patent/SK10472003A3/sk not_active Application Discontinuation
- 2002-02-22 IL IL15744602A patent/IL157446A0/xx unknown
-
2003
- 2003-07-31 ZA ZA200305909A patent/ZA200305909B/en unknown
- 2003-08-13 BG BG108087A patent/BG108087A/bg unknown
-
2004
- 2004-01-30 HK HK04100666.9A patent/HK1059267A1/xx not_active IP Right Cessation
-
2006
- 2006-11-22 US US11/603,544 patent/US7544784B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1366062A2 (en) | 2003-12-03 |
WO2002068455A2 (en) | 2002-09-06 |
US20020182665A1 (en) | 2002-12-05 |
RU2003127830A (ru) | 2005-04-10 |
CN1547586A (zh) | 2004-11-17 |
HK1059267A1 (en) | 2004-06-25 |
US7544784B2 (en) | 2009-06-09 |
MXPA03007563A (es) | 2003-12-11 |
US20070270577A1 (en) | 2007-11-22 |
CA2438094A1 (en) | 2002-09-06 |
ES2370235T3 (es) | 2011-12-13 |
KR20040052481A (ko) | 2004-06-23 |
SK10472003A3 (sk) | 2004-03-02 |
CA2438094C (en) | 2011-10-11 |
CZ20032208A3 (cs) | 2004-01-14 |
AU2002255600B2 (en) | 2008-01-24 |
ZA200305909B (en) | 2004-06-04 |
JP2005505494A (ja) | 2005-02-24 |
ATE517909T1 (de) | 2011-08-15 |
EE200300408A (et) | 2003-12-15 |
BG108087A (bg) | 2005-04-30 |
EP1366062B1 (en) | 2011-07-27 |
RU2316563C2 (ru) | 2008-02-10 |
PL374045A1 (en) | 2005-09-19 |
US7157557B2 (en) | 2007-01-02 |
WO2002068455A3 (en) | 2003-09-18 |
HUP0303246A2 (hu) | 2003-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL157446A0 (en) | Increased recovery of active proteins | |
BE2016C015I2 (bg) | ||
EP2298331A3 (en) | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins | |
EA200700917A1 (ru) | Способ рефолдинга рекомбинантных антител | |
PL1641483T3 (pl) | Białka fuzyjne | |
WO2005021579A3 (en) | Epo mimetic peptides and fusion proteins | |
ATE408631T1 (de) | Chimäres protein welches eine intramolekulare chaperon-ähnliche sequenz enthält und dessen anwendung zur insulinproduktion | |
DK1368372T3 (da) | Peptid med affinitet til det virale gp120-protein samt anvendelse deraf | |
HK1082510A1 (en) | Promoter to il-18bp, its preparation and use | |
WO2003022883A3 (de) | Verwendung eines proteins zur herstellung eines medikaments zur stimulierung des angeborenen unspezifischen immunsystems | |
WO2002038765A3 (en) | Dna encoding bovine immunoglobulin a inducing protein and uses therefor | |
AU2013245463B2 (en) | Immunoglobulin Chimeric Monomer-Dimer Hybrids | |
WO2003048320A3 (en) | Novel motor protein of p. falciparum and methods for its use |